Sristek

Hyderabad, India Founded: 2002 • Age: 24 yrs Acquired By Indovation Technologies
Clinical trials, data management, biostatistics, and pharmacovigilance services are provided.

About Sristek

Sristek is a Healthcare company based in Hyderabad (India) founded in 2002, and was acquired by Indovation Technologies in October 2014. Clinical trials, data management, biostatistics, and pharmacovigilance services are provided. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity in India is Sristek Clinical Research Solutions Limited (U74900TG2002PLC039366).

Company details

Sristeks offerings include clinical trial, clinical data management, biostatics, medical affairs and Pharmacovigilance services. The company is capable of conducting multi-center, multi-geography clinical trials as well as for offering end to end solutions for clinical data management, biostatistics, programming, medical writing and pharmacovigilance projects. Mindomatics, their only product, is a set of computerised psychometric tests that can be used for evaluating the impact of drugs on the brain and central nervous system. These tests evaluate the effects of well-understood drugs as well as new drugs by testing and assessing various aspects. They claim they have the required expertise to navigate regulatory requirements of IND, ANDA, WHO and various other local regulatory agencies.The company has operations in India, US,UK, Canada, Philippines, Bangladesh and partnerships in Eastern and Western Europe, China and other South East Asian nations. They are currently conducting clinical trials in 11 different therapeutic areas in various phases. It was acquired by Indovation Technologies

Key Metrics

Investors in Sristek

Sristek has secured backing from 1 investor. Prominent investors backing the company include Indovation Technologies.

All
InvestorDescriptionFounded YearDomainLocation
Limited information available
indovation.co.inVisakhapatnam, India
Premium access

Investor details for Sristek

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Sristek Clinical Research Solutions Limited (Sristek)

Sristek Clinical Research Solutions Limited is the primary company behind Sristek. The board of Sristek Clinical Research Solutions Limited currently have 3 directors; the longest-serving is Meesala Sai Bhakta Chalapathi Rao, appointed in 2005. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Meesala Sai Bhakta Chalapathi Rao
DIN 01764287
Director14 Sep 200521 yrs 2 moSristek Clinical Research Solutions Limited
Meesala Sampath Kumar
DIN 00022155
Director14 Sep 200521 yrs 2 moSristek Clinical Research Solutions Limited
Sai Lakshmi Meesala
DIN 05171559
Additional Director07 Aug 201313 yrs 3 moSristek Clinical Research Solutions Limited

People of Sristek

1 people are tracked at Sristek (1 in leadership).

NameRoleGroup
OwnerLeadership
Premium access

Complete people profiles for Sristek

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Sristek

2 dated milestones of Sristek across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sristek is founded.
  2. Exit Acquired by Indovation Technologies.

Web traffic of Sristek

Websites that share an audience with Sristek (sristek.com).

Similar websites

Websites whose visitors overlap most with Sristek. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
gvkbio.com
26%
View details

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Sristek (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sristek

Sristek was founded in 2002.

Sristek is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Sristeks offerings include clinical trial, clinical data management, biostatics, medical affairs and Pharmacovigilance services. The company is capable of conducting multi-center, multi-geography clinical trials as well as for offering end to end solutions for clinical data management, biostatistics, programming, medical writing and pharmacovigilance projects. Mindomatics, their only product, is a set of computerised psychometric tests that can be used for evaluating the impact of drugs on the brain and central nervous system. These tests evaluate the effects of well-understood drugs as well as new drugs by testing and assessing various aspects. They claim they have the required expertise to navigate regulatory requirements of IND, ANDA, WHO and various other local regulatory agencies.The company has operations in India, US,UK, Canada, Philippines, Bangladesh and partnerships in Eastern and Western Europe, China and other South East Asian nations. They are currently conducting clinical trials in 11 different therapeutic areas in various phases. It was acquired by Indovation Technologies.

Sristek has 1 investor. Key investors include Indovation Technologies.

Sristek operates through Sristek Clinical Research Solutions Limited.

Yes. Sristek was acquired by Indovation Technologies in October 2014.

The legal entities of Sristek currently have 3 directors, including Meesala Sai Bhakta Chalapathi Rao, Sai Lakshmi Meesala, Meesala Sampath Kumar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available